Similar articles

• Risk stratification in chronic lymphocytic leukemia.

  Seiler T, Döhner H, Stilgenbauer S. Seiler T, et al. Semin Oncol. 2006 Apr;33(2):186-94. doi: 10.1053/j.seminoncol.2006.01.017. Semin Oncol. 2006. PMID: 16616065 Review.
• Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.

  D'Arena G, Tarnani M, Rumi C, Vaisitti T, Aydin S, De Filippi R, Perrone F, Pinto A, Chiusolo P, Deaglio S, Malavasi F, Laurenti L. D'Arena G, et al. Am J Hematol. 2007 Sep;82(9):787-91. doi: 10.1002/ajh.20936. Am J Hematol. 2007. PMID: 17534928
• Validation of a targeted DNA microarray for the clinical evaluation of recurrent abnormalities in chronic lymphocytic leukemia.

  Patel A, Kang SH, Lennon PA, Li YF, Rao PN, Abruzzo L, Shaw C, Chinault AC, Cheung SW. Patel A, et al. Am J Hematol. 2008 Jul;83(7):540-6. doi: 10.1002/ajh.21145. Am J Hematol. 2008. PMID: 18161787 Clinical Trial.
• Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.

  Bomben R, Dal Bo M, Capello D, Forconi F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Zucchetto A, Bertoni F, Rossi FM, Bulian P, Cattarossi I, Ilariucci F, Sozzi E, Spina V, Zucca E, Degan M, Lauria F, Del Poeta G, Efremov DG, Marasca R, Gaidano G, Gattei V. Bomben R, et al. Br J Haematol. 2009 Feb;144(4):492-506. doi: 10.1111/j.1365-2141.2008.07469.x. Epub 2008 Nov 19. Br J Haematol. 2009. PMID: 19036101
• Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL.

  Shanafelt TD, Geyer SM, Kay NE. Shanafelt TD, et al. Blood. 2004 Feb 15;103(4):1202-10. doi: 10.1182/blood-2003-07-2281. Epub 2003 Oct 23. Blood. 2004. PMID: 14576043 Review.